Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Macrogenics
Macrogenics
Incyte grabs a new PD-1 checkpoint drug in $900M deal with MacroGenics
Endpoints
Wed, 10/25/17 - 09:44 am
Incyte
PD-1 inhibitors
Macrogenics
MGA012
Neurotoxicity kills a CAR-T rival pushed by J&J, MacroGenics in $700M deal
Endpoints
Fri, 09/1/17 - 11:31 pm
JNJ
CAR-T
Macrogenics
MGD011
MacroGenics scores drug licensing deal worth up to $740 million
Bizjournals.com
Fri, 05/20/16 - 10:23 am
Macrogenics
Janssen
MGD015
cancer immunotherapy
MacroGenics Announces Date of Fourth Quarter and Full Year 2014 Financial Results Conference Call
CNN Money
Wed, 02/25/15 - 07:56 am
Macrogenics
earnings
MacroGenics Partners With J&J; Stock Jumps
Investors.com
Mon, 12/22/14 - 01:17 pm
Macrogenics
JNJ
Janssen Biotech
MGD011
3 Biotech Stocks Falling Like a Knife: Puma Biotechnology, MacroGenics, and Aratana Therapeutics
Motley Fool
Tue, 04/15/14 - 01:50 pm
Puma Biotechnology
Macrogenics
neratinib
Aratana
MGD007
Pulse of J.P. Morgan 2014: Interviews with 17 biopharma execs
Fierce Biotech
Fri, 01/17/14 - 05:54 pm
JPMHC 2014
Algeta
Macrogenics
Xencor
Acetylon
Enanta Pharmaceuticals
Clinigen
Iroko Pharmaceuticals
Protalix BioTherapeutics
Ambrx
Roche
Sialix
Verastem
pRED
Cubist Pharmaceuticals
Celgene
Otonomy
Lumena Pharmaceuticals
The Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10
Forbes
Sat, 01/11/14 - 10:13 am
Neurocrine
Intercept Pharma
Epizyme
Sangamo BioSciences
OncoMed
Zogenix
Macrogenics
Intrexon
Pharmacyclics
Galena Biopharma
MacroGenics - Cancer IPOs Remain The Hottest Thing In Town
Seeking Alpha
Mon, 10/14/13 - 09:29 am
IPOs
Macrogenics
Pfizer
Gilead
FierceBiotech's 2013 Fierce 15
Fierce Biotech
Wed, 09/25/13 - 01:04 pm
biotech
AnaptysBio
Acetylon Pharmaceuticals
CytomX
Immunocore
FibroGen
Jounce Therapeutics
Kala Pharmaceuticals
Macrogenics
Moderna Therapeutics
Presage Biosciences
Nimbus Discovery
Scioderm
Ultragenyx
uniQure
Visterra
MacroGenics trumpets cancer immunotherapies in $60M IPO pitch
Fierce Biotech
Thu, 09/5/13 - 08:56 am
Macrogenics
cancer immunotherapy
IPOs
Firm ranks top 5 biotech deals in evolving pharma R&D landscape
Fierce Biotech
Fri, 04/12/13 - 01:56 pm
biotech
M&A
Otsuka
Lundbeck
Gilead
Macrogenics
Roche
Chiasma
Edison Pharma
Dainippon
Moderna
AstraZeneca
Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships
Seeking Alpha
Sun, 10/31/10 - 11:35 am
Teva Pharmaceuticals
Sanofi
Pfizer
Pacific Biosciences
Merck
Macrogenics
Hikma
GSK
BMP Sunstone
biotech
Baxter International
Amicus Therapeutics
Immune Design
MedImmune
MacroGenics, Pfizer sign collaboration deal
Yahoo/AP
Wed, 10/27/10 - 11:43 am
Pfizer
Macrogenics
cancer
Lilly, MacroGenics Say Diabetes Treatment Misses Goal in Late-Stage Study
Bloomberg
Wed, 10/20/10 - 09:38 pm
diabetes
Macrogenics
Eli Lilly
teplizumab
Bankers Reveal Top Biotech IPO Contenders; New Filer Ironwood Among Them
BNET Pharma
Tue, 11/24/09 - 09:54 am
biotech
IPOs
Ironwood
Trius Therapeutics
Portola Pharmaceuticals
Pacific Biosciences
Regulus
Concert Pharmaceuticals
Macrogenics
Pages
« first
‹ previous
1
2